Ensuring our investments do good and do well.
Our investment criteria is unique in the venture community. We believe in deep diligence and review nearly 1000+ companies each year, selecting only those that we believe in.
We see the potential in life science innovation to enable technologies for healthcare product development and care delivery tools. We are also a business builder, committed to investing in strong positioned companies that have the potential to improve operationally, strategically and financially. More importantly, we think about the future technology advancements in healthcare differently.
Technology that has a primary medical application. We prefer technologies that will be directly used by patients or consumers.
The technology represents a 10X magnitude of improvement over current standard of care, or has no equivalent.
Low regulatory requirement
Any technology except for those considered a pharmaceutical by the FDA. We prefer 510K approval pathways, or those with similar timeframes.
Strong and defensible IP
We prefer unique hardware and IP coupled with unique software.
Technology has the potential to be used as a platform for multiple medical, and possibly non-medical, applications.
Early in the journey
Companies that are currently raising in the seed round or before any regulatory approval but with some feasibility work done.
A business model that is unique and has a high chance of significant (~$100M) revenue in less than 5 years.
A management team with previous success in medical device startups and exits. We aim to help our portfolio companies start strong.